Cargando…
Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment
The last few years important changes have occurred in the field of diabetes treatment. The priority in the therapy of patients with diabetes is not glycemic control per se rather an overall management of risk factors, while individualization of glycemic target is suggested. Furthermore, regulatory a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855136/ https://www.ncbi.nlm.nih.gov/pubmed/35211246 http://dx.doi.org/10.4239/wjd.v13.i2.85 |